Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
Clinical trial NCT04083898 · TERMINATED
Trial details
- NCT number
- NCT04083898
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-03
- Primary completion
- 2023-03-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.